1. Pierce D, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000 Aug;154(2):178-86.
2. Kato Kazuo, Sawada Shozo. Medical X-ray Doses’ Contributions to the Ionizing Radiation Exposures of Atomic-Bomb Survivors. J Radiat Res. 2016 Nov;57(6):583-95.
3. Chekin SYu, Maksyutov MA, Kashcheev VV, Menyajlo AN, Vlasov OK, Shchukina NV, et al. Prognosis of the long-term medical radiological consequences of the Chernobyl disaster for citizens of Russia and the Republic of Belarus on the main radiation-related diseases. Radiation and Risk. 2016;25(4):7-19. (Russian).
4. Ivanov VK, Rastopchin EM, Chekin SYu, Ryvkin VB. Oncological morbidity and mortality among participants in the liquidation of the consequences of the Chernobyl disaster: an assessment of radiation risks. Radiation and Risk. 1995;6:123-55. (Russian).
5. Tukov AR, Biryukov AP, Shafranskij IL. The use of data on the doses of various types of irradiation in radiation epidemiology. Medical Radiology and Radiation Safety. 2014;59(1):43-9. (Russian).
6. Tsovyanov AG, Kosterev VV, Kryuchkov VP, Romanov VV, Pocyapun NP, Kuhta BA, Sivenkov A.G. Informational and analytical reference book “Doses of exposure of personnel of organizations and the population in the territories served by FMBA of Russia and the Ministry of Defense of Russia in 2010”. Moscow. 2012. 86 p. (Russian).
7. EPICURE, Users Guide. Preston DL, Lubin JH, Pierce DA, McConney ME. HiroSoft International Corporation. Seattle, WA 98112, USA. 1993. 329 p.
8. Tsyb AF, Ivanov VK, Biryukov AP. Possibilities of radiation epidemiology in solving radiation safety problems of medical exposure. Radiation and Risk. 2008;17(2):50-62. (Russian).
9. Kato K, Antoku S, Russell WJ, Fujita S, Pinkston J.A, Hayabuchi N, et al. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki. Radiat Res. 1998 Jun;149(6):614-24.



